Thanks to the phytosome technology, it is possible to combine two phospholipids together into an innovative formulation. As a result, the specific properties of each phospholipid are enhanced to create a unique and synergistic effect.

An example of this technology is Eye Pharma’s development of the CASPERIVA® formulation. This formulation combines the anti-inflammatory and antioxidant properties of curcuminoids extracted from the root of Curcuma longa, with the antiangiogenic properties of boswellic acids, particularly AKBA, extracted from the resin of the Boswellia Serrata tree.

This technology is a blend of active ingredients designed to create a synergistic effect and multifactorial efficacy.

Primarily, this technology provides greater bioavailability, which means a higher, faster, and constant absorption of these two phospholipids by the body.

 

This technology enables phospholipids to reach the retinal tissues with greater selectivity and specificity.

An innovative blend of active ingredients with synergistic actions and high bioavailability in the phytosome technology strengthens the efficacy of its individual components.